A CD36 neutralizing antibody inhibited metastasis of human melanoma and breast cancer cells[72], and inhibition of CPT1 caused mitochondrial damage leading to cell death in primary AML cells[67]. The gene discussed is CPT1A; the disease is breast carcinoma.